Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00509353
Status:
COMPLETED
Last Update Posted:
2023-11-09
First Post:
2007-07-30
Brief Title:
N2004-06 Irinotecan and Vincristine With 131I-MIBG Therapy for ResistantRelapsed High-Risk Neuroblastoma
Sponsor:
Childrens Hospital Los Angeles
Organization:
Childrens Hospital Los Angeles
Organization Data
Organization:
Childrens Hospital Los Angeles
Class:
OTHER
Study ID:
CDR0000558042
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Childrens Hospital Los Angeles
Lead Sponsor Class:
OTHER
Responsible Party:
Araz Marachelian
Responsible Party Title:
Medical Director
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Childrens Hospital Los Angeles
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |